Cargando…
Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report
Hemolytic uremic syndrome (HUS) is defined by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). Atypical HUS (aHUS), distinguished by its etiology, is caused by uncontrolled overactivation of the alternative complement pathway. The correct diagnosis of...
Autores principales: | Bogdał, Anna, Badeński, Andrzej, Pac, Małgorzata, Wójcicka, Anna, Badeńska, Marta, Didyk, Agnieszka, Trembecka-Dubel, Elżbieta, Dąbrowska-Leonik, Nel, Walaszczyk, Małgorzata, Matysiak, Natalia, Morawiec-Knysak, Aurelia, Szczepański, Tomasz, Szczepańska, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430959/ https://www.ncbi.nlm.nih.gov/pubmed/34502390 http://dx.doi.org/10.3390/ijms22179479 |
Ejemplares similares
-
Assessment of Brain-Derived Neurotrophic Factor (BDNF) Concentration in Children with Idiopathic Nephrotic Syndrome
por: Badeński, Andrzej, et al.
Publicado: (2022) -
Assessment of Interleukin-15 (IL-15) Concentration in Children with Idiopathic Nephrotic Syndrome
por: Badeński, Andrzej, et al.
Publicado: (2023) -
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021) -
Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015) -
Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020)